✦ LIBER ✦

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Scribed by Hayes, D.F.

Book ID: 122982147
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 61 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80272-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomic Predictor of Sensitivity

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Hess, K. R.; Anderson, K.; Symmans, W. F.; Valero, V.; Ibrahim, N.; Mejia, J. A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 362 KB

Evaluation of a 30-Gene Paclitaxel, Fluo

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

✍ Tabchy, A.; Valero, V.; Vidaurre, T.; Lluch, A.; Gomez, H.; Martin, M.; Qi, Y.; 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 343 KB

Neoadjuvant chemotherapy paclitaxel + do

Neoadjuvant chemotherapy paclitaxel + doxorubicin (PD) vs fluorouracil + doxorubicin + cyclophosphamide (FAC) in locally advanced breast cancer: Clinical and pathological response

✍ V.F. Semiglazov; A.A. Bojok; A.S. Arsumanov; O.A. Ivanova; V.G. Ivanov; V.V. Sem 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Benefit of the Addition of Paclitaxel to

Benefit of the Addition of Paclitaxel to Standard Chemotherapy with 5-Fluorouracil/Doxorubicin/Cyclophosphamide in Patients with Operable Breast Cancer

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 80 KB

1–39 Gene Expression Profiles Predict Co

1–39 Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

✍ Carey, L.A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Neoadjuvant chemotherapy with cyclophosp

Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer

✍ Pankaj Gupta; Loveleen Bilani; Gaur K. Rath; Anoop Misra; Mahesh C. Mishra; Nuta 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 340 KB